Heart failure (HF) is a prevalent and debilitating cardiovascular condition associated with
high morbidity and mortality rates. Early detection is crucial for improving prognosis and
reducing hospitalizations, but traditional diagnostic methods often lack sensitivity and
specificity. Over recent years, significant advancements have been made in the development
of cardiac biomarkers for early detection of HF. This review explores the current state of
knowledge surrounding cardiac biomarkers, their roles in HF detection, and emerging trends
in the field. It also discusses the challenges and future prospects for implementing these
biomarkers in clinical practice.
You may also start an advanced similarity search for this article.